Market research
ALBIO.PA Biosynex SA
PA EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 12.6
- Dividend yield
- Not available
- Beta
- 0.83
Community
Investor discussion
1 comment
Sign in to join the ALBIO.PA discussion.
5 years, 5 months ago
Biosynex SA is currently in a long term uptrend where the price is trading 24.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Based on the above factors, Biosynex SA gets an overall score of 2/5.